.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Chubb
UBS
Teva
US Department of Justice
Cantor Fitzgerald
Medtronic
Fuji
Merck
Accenture

Generated: July 22, 2017

DrugPatentWatch Database Preview

CIDOFOVIR Drug Profile

« Back to Dashboard

Which patents cover Cidofovir, and what generic Cidofovir alternatives are available?

Cidofovir is a drug marketed by Emcure Pharms Ltd and Mylan Institutional and is included in two NDAs.

The generic ingredient in CIDOFOVIR is cidofovir. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cidofovir profile page.

Summary for Tradename: CIDOFOVIR

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list42
Clinical Trials: see list39
Patent Applications: see list4,641
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CIDOFOVIR at DailyMed

Pharmacology for Tradename: CIDOFOVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd
CIDOFOVIR
cidofovir
INJECTABLE;INJECTION202501-001Jul 26, 2012APRXNoNo► Subscribe► Subscribe
Mylan Institutional
CIDOFOVIR
cidofovir
INJECTABLE;INJECTION201276-001Jun 27, 2012APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
AstraZeneca
Citi
Julphar
Moodys
Accenture
Mallinckrodt
Farmers Insurance
Colorcon
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot